Angiotensin II type 1 (AT1) receptor blockade enhances the L-NAME-induced vasoconstriction in rat submandibular gland

被引:3
|
作者
Vág, J
Kerémi, B
Hably, C
Bartha, J
Fazekas, A
机构
[1] Semmelweis Univ, Dept Conservat Dent, H-1088 Budapest, Hungary
[2] Semmelweis Univ, Dept Physiol, H-1088 Budapest, Hungary
关键词
D O I
10.1113/eph8702330
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The vasoregulatory role of nitric oxide (NO) and angiotensin II type 1 (AT(1)) receptors in the circulation of the submandibular gland (SMG) of rats was studied. The glandular blood flow was determined by means of laser Doppler flowmetry and rubidium isotope technique. The data obtained by these two methods correlated well (r = 0.77; P < 0.01). The AT(1) receptor antagonist candesartan (0.5 mg kg(-1), I.V.) reduced the vascular resistance in the SMG by 37% (P < 0.05). By contrast, the NO synthase blocker L-NAME (15 mg kg(-1), I.V.) significantly increased vascular resistance in the SMG both in candesartan-treated (P < 0.001) and non-treated (P < 0.001) animals. The increase in resistance was greater (P < 0.05) after previous blockade of AT(1) receptors. These findings suggest that the AT(1) receptors have an important role in the vasoregulation of the SMG in the rat. As a result of AT(1) blockade, NO-dependent tone of glandular vessels may be enhanced significantly.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 50 条
  • [1] Evidence for the AT1 subtype of the angiotensin II receptor in the rat submandibular gland
    Matsubara, S
    Saito, K
    Kizawa, Y
    Sano, M
    Osawa, M
    Iwamoto, K
    Murakami, H
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (10) : 1185 - 1188
  • [2] Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland
    Sanchez-Lemus, Enrique
    Murakami, Yuki
    Larrayoz-Roldan, Ignacio M.
    Moughamian, Armen J.
    Pavel, Jaroslav
    Nishioku, Tsuyoshi
    Saavedra, Juan M.
    [J]. ENDOCRINOLOGY, 2008, 149 (10) : 5177 - 5188
  • [3] Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy
    Azegami, Tatsuhiko
    Sasamura, Hiroyuki
    Hayashi, Kaori
    Itoh, Hiroshi
    [J]. HYPERTENSION RESEARCH, 2012, 35 (05) : 492 - 499
  • [4] Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy
    Tatsuhiko Azegami
    Hiroyuki Sasamura
    Kaori Hayashi
    Hiroshi Itoh
    [J]. Hypertension Research, 2012, 35 : 492 - 499
  • [5] Increased renal injury with AT1 receptor blockade in salt-sensitive hypertension but not L-NAME-induced hypertension
    Rudd, MA
    Maitland, K
    Davis, W
    Loscalzo, J
    [J]. HYPERTENSION, 2005, 46 (04) : 826 - 826
  • [6] Inhibition of the expression of the gene for the angiotensin AT1 receptor by angiotensin II in the rat adrenal gland
    Ishihata, A
    Uno, S
    Guo, DF
    Katano, Y
    Inagami, T
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (01) : 129 - 139
  • [7] Add on of Direct AT2 Receptor Stimulation to AT1 Receptor Blockade: The Effect on Aortic Remodeling and PWV in L-NAME-Induced Hypertension
    Paulis, Ludovit
    Schwengel, Katja
    Lucht, Kristin
    Becker, Sophie
    Kashina, Elena
    Baulmann, Johannes
    Unger, Thomas
    Steckelings, Ulrike M.
    [J]. HYPERTENSION, 2011, 58 (05) : E45 - E45
  • [8] Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor
    Lin, Yan-Jie
    Kwok, Ching-Fai
    Juan, Chi-Chang
    Hsu, Yung-Pei
    Shih, Kuang-Chung
    Chen, Chin-Chang
    Ho, Low-Tone
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 451 (02) : 263 - 269
  • [9] Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
    Benicky, Julius
    Sanchez-Lemus, Enrique
    Honda, Masaru
    Pang, Tao
    Orecna, Martina
    Wang, Juan
    Leng, Yan
    Chuang, De-Maw
    Saavedra, Juan M.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2011, 36 (04) : 857 - 870
  • [10] Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
    Julius Benicky
    Enrique Sánchez-Lemus
    Masaru Honda
    Tao Pang
    Martina Orecna
    Juan Wang
    Yan Leng
    De-Maw Chuang
    Juan M Saavedra
    [J]. Neuropsychopharmacology, 2011, 36 : 857 - 870